Analytical methods | |||
---|---|---|---|
Comparative study | #1 | #2 | |
Chromatography | GC | GC | |
Ion source | EI | EI | |
Positive/Negative mode | – | – | |
Mass analyzer | – | – | |
Identification level | – | – |
Sample information | |||
---|---|---|---|
Comparative study | #1 | #2 | |
Country | Germany | Germany | |
Specimen | exhaled breath | exhaled breath | |
Marker function | diagnosis | diagnosis | |
Participants(Case) | Cancer type | NSCLC, SCLC | NSCLC, SCLC |
Stage | – | – | |
Number | 12 | 12 | |
Gender (M,F) | 11, 1 | 11, 1 | |
Mean age (range) (M,F) | – | – | |
Smoking status | – | – | |
Participants(Control) | Type | healthy | healthy |
Number | 24 | 24 | |
Gender (M,F) | 10, 14 | 10, 14 | |
Mean age (range) (M,F) | – | – | |
Smoking status | smoker, non-smoker | smoker, non-smoker |
Data processing and metabolite identification | |
---|---|
Data processing software | – |
Database search | – |
Statistical analysis | |
---|---|
Differential analysis method | – |
Classification method | – |
Survival analysis method | – |
Metabolite | Author-emphasized biomarkers | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
---|---|---|---|---|---|---|---|
nonanal | – | – | – | – | 0.03 | – | – |
octanal | – | – | – | – | 0.01 | – | – |
hexanal | – | – | – | – | 6.00e-03 | – | – |
pentanal | – | – | – | – | 1.00e-03 | – | – |
CEA | – | – | – | – | – | – | – |
CYFRA 21-1 | – | – | – | – | – | – | – |
NSE | – | – | – | – | – | – | – |
Metabolite | Author-emphasized biomarkers | Cutoff value | AUROC (95%CI) | Sensitivity (%) | Specificity (%) | Accuracy (%) |
---|---|---|---|---|---|---|
nonanal | – | 8.433 nmol/L | – | 33.3 | 95.8 | – |
octanal | – | 1.068 nmol/L | – | 58.3 | 91.7 | – |
hexanal | – | 1.208 nmol/L | – | 8.3 | 91.7 | – |
pentanal | – | 0.275 nmol/L | – | 75 | 95.8 | – |
CEA | – | 5.61 ng/mL | – | 58.3 | 95.7 | – |
CYFRA 21-1 | – | 3.34 ng/mL | – | 66.7 | 100 | – |
NSE | – | 22.85 ng/mL | – | 50 | 91.3 | – |